-
Scale-up of integrated HIV services had reached the following number of sites:
-
724 static (579 within and 145 outside of health facilities) and 188 outreach HTC sites
-
711 (static) ART sites
-
601 PMTCT sites (Option B+, all included in ART sites above)
-
662 Pre-ART sites
-
642 sites with HIV-exposed child follow-up
-
493,567 persons were tested and counselled for HIV; 150,728 (31%) accessed HTC for the first time;
342,839 (69%) were repeat testers and 9,820 (3%) of these received confirmatory testing (after
having tested positive in the past). This is equivalent to 35% confirmatory testing coverage among
25,957 patients initiating ART this quarter. 29,285 (6%) clients received a positive result for the first
time.
-
19,596 (95%) of 20,538 blood units collected were screened for (at least) HIV, hepatitis B and
syphilis.
-
141,212 (91%) of 155,272 women at ANC had their HIV status ascertained; 10,766 (8%) of these
were HIV positive. 120,781 (96%) of 125,961 women at maternity had their HIV status ascertained
8,967 (7%) of these were HIV positive.
-
25,957 patients started ART this quarter.
-
568,470 patients were alive and on ART by end of June 2015. This means that 57% of the estimated
1 million HIV positive population was on ART. 1 Estimated ART coverage among people in need for
treatment1 was 49% (49,407 / 101,000) for children (<15 years) and 67% (519,063 / 779,000) for
adults.
-
79% of adults and 78% of children were retained alive on ART at 12 months after initiation. Actual
retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as
defaulters in clinic-based survival/retention analysis. (see section 16.4)
-
493,034 (93%) of 531,106 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).
-
10,460 (70%) of an estimated 14,926 HIV infected pregnant women in Malawi were on ART this
quarter. 5,960 (57%) of these were already on ART when getting pregnant and 4,500 (43%) started
ART during pregnancy/delivery.
-
An additional 1,591 breastfeeding women started ART due to Option B+ (in WHO stage 1/2)
-
76%, 72%, 67% and 69% of women started under Option B+ were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.
-
8,210 (7%) of infants discharged alive from maternity were known to be HIV exposed, 7,771 (95%)
of these received ARV prophylaxis (nevirapine). 6,563 (80%)were enrolled in exposed child followup
before age 2 months.
- A total of 10,396 HIV exposed children and 6,077 pre-ART patients were enrolled for follow-up in
HIV Care Clinics (HCC) during this quarter.
